National Comprehensive Cancer Network

About NCCN

NCCN News

NCCN welcomes the opportunity to work with reporters on all cancer-related topics. NCCN offers members of the media access to scientific and medical experts, news releases, background research, and much more. We can also help connect press with investigators and clinicians who can discuss research, treatment and issues related to cancer through coordination with media contacts at NCCN Member Institutions.

For news, interviews, photo requests or the most current information and resources available, please contact:

Katie Kiley Brown
Communications Manager
215.690.0238
brown@nccn.org
Request an Interview

Note: NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a license and review of content.

Newsroom

Press kits, media advisories, and information on upcoming events.

Press Releases

• NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies  (09/28/2016)
• NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms  (09/26/2016)
• NCCN Imaging Appropriate Use Criteria to be Integrated into New Century Health’s Oncology Clinical Decision Support Platform  (09/15/2016)
• Electronic Health Record Data Can Help Determine Highest Risk of Early Death from Chemotherapy in Older Patients with Lymphoma  (09/07/2016)

View more >

NCCN eBulletin Newsletter

September 12, 2016 | Volume 8 Issue 17

• NCCN Awards 3 Grants to Investigators to Study Bavituximab in Combination with Other Therapeutic Strategies in Various Cancers
• Electronic Health Record Data Can Help Determine Highest Risk of Early Death from Chemotherapy in Older Patients with Lymphoma
• Updated Patient Resources Now Available for Melanoma and Non-Small Cell Lung Cancer
• NCCN Flash Update: NCCN Guidelines^® & NCCN Compendium^® Updated

August 29, 2016 | Volume 8 Issue 16

• New NCCN Imaging Appropriate Use Criteria Published for Eight Cancer Types
• The Days of Biosimilars and Molecular Testing Are Here; Are We Ready?
• NCCN Imaging Appropriate Use Criteria to be Integrated into MedCurrent’s OrderWise Platform
• NCCN Flash Updates™: NCCN Templates^® Updated

View more >

NCCN in the News

• NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies  (09/28/2016)
• NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms  (09/26/2016)
• NCCN Imaging Appropriate Use Criteria to be Integrated into New Century Health’s Oncology Clinical Decision Support Platform  (09/15/2016)
• Electronic Health Record Data Can Help Determine Highest Risk of Early Death from Chemotherapy in Older Patients with Lymphoma  (09/07/2016)

View more >

NCCN Member Institutions the News

• NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms  (09/26/2016)
• There’s New Hope for Blood Cancer, and It Comes from Umbilical Cords (The Washington Post)  (09/05/2016)
• New Drugs for Ovarian Cancer Patients (The Wall Street Journal)  (09/05/2016)
• Obesity Linked to Improved Survival in Kidney Cancer (Dana-Farber Cancer Institute)  (09/05/2016)

View more >